Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. Detailed report on acquisition of treasury shares.pdfDetailed report on acquisition of treasury shares

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 17 / 2026
Date of issue: 2026-04-03
Short name of the issuer
KRKA
Subject
Acquisition of treasury shares
Official market - legal basis
Unofficial market - legal basis
Contents of the report:
Based on the provisions of the Rules of the Ljubljana Stock Exchange, d. d., Ljubljana and Article 2 of the Commission Delegated Regulation (EU) 2016/1052 Krka, d. d., Novo mesto announces:

With a reference to the public notice from 20 July 2023, Krka is publicly disclosing information on transactions relating to buy-back programme in the period from 27 March 2026 up to and including 2 April 2026. Krka acquired 4,947 treasury shares in the total value of EUR 1,148,197 the Ljubljana Stock Exchange as follows:

- on 27 March 2026: 1,102 shares at a VWAP of EUR 229.94,
- on 30 March 2026: 1,203 shares at a VWAP of EUR 230.00,
- on 31 March 2026: 703 shares at a VWAP of EUR 233.34,
- on 1 April 2026: 996 shares at a VWAP of EUR 234.52 and
- on 2 April 2026: 943 shares at a VWAP of EUR 233.82.

Price is calculated as volume weighted average price (VWAP).
Ilirika d.d., Intercapital d.d. and NLB d.d. were brokers in these transactions. Detailed report on acquisition of treasury shares attached.

The total number of treasury shares prior to these transactions was 2,493,184 representing 7.603% of all shares issued.
The total number of treasury shares after these transactions is 2,498,131 representing 7.618% of all shares issued.

The notice will be published on the Company's website (www.krka.biz) from 3 April 2026 onwards, for a minimum period of 5 years.
Annexes
File Description
Detailed report on acquisition of treasury shares.pdf
Detailed report on acquisition of treasury shares.pdf
Detailed report on acquisition of treasury shares

KRKA, TOVARNA ZDRAVIL D.D.
(fullname of the issuer)
KRKA Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
8501 Nove Mesto
(post code) (city)
Smarjeska 6
(street) (number)
+386 7 331 21 11 +386 7 332 15 37
(phone number) (fax)
(e-mail) (web site)
nie dotyczy
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2026-04-03 Jože Colarič President of the Management Board and CEO
20260403_113456_0248277511_Detailed_report_on_acquisition_of_treasury_shares.pdf